Inactive Instrument

All News Motif Bio plc

Equities

MTFB

GB00BVVT4H71

All News

Unlock all the news: Be the first to know and act before the market!

MOTF BIO : BiVictriX Debuts on London's AIM Segment After $10 Million IPO	11/21/11	MT
Motif Bio plc Announces Board Appointments	14/21/14	CI
BiVictriX Therapeutics Ltd. cancelled the acquisition of Motif Bio plc in a reverse merger transaction.	14/21/14	CI
Motif Bio plc Reports Earnings Results for the Full Year Ended December 31, 2020	10/21/10	CI
Motif Bio : 2020 Annual Report and Accounts	10/21/10	PU
Motif Bio plc Announces Board Changes	10/21/10	CI
Orange Avenue Technologies LLC entered into a Stock Purchase Agreement to acquire Motif BioSciences, Inc. from Motif Bio plc	26/21/26	CI
Motif Bio : Signs Reverse Takeover of Antibody-Drug Conjugate Company	27/21/27	MT
BiVictriX Therapeutics Ltd. entered into a sale and purchase agreement to acquire Motif Bio plc for £5.5 million in a reverse merger transaction.	27/21/27	CI
Motif Bio plc Reports Earnings Results for the Half Year Ended June 30, 2020	12/20/12	CI
Motif Bio : Results of AGM	30/20/30	PU
Motif Bio : Notification of Interim Results	23/20/23	PU
Motif Bio : Annual Report and Accounts & Notice of AGM	09/20/09	PU
Motif Bio plc Reports Earnings Results for the Full Year Ended December 31, 2019	01/20/01	CI
Motif Bio : Delay in publication of Final Results	22/20/22	PU
Motif Bio plc Announces Delay in Publication of Final Results for the Year Ended 31 December 2019	22/20/22	CI
Motif Bio : Business Update and Appointment of Strategic Adviser	02/20/02	AQ
Motif Bio Appoints Adviser for Reverse Takeover Candidate	01/20/01	CI
Motif Bio : Exercise of Warrants	18/20/18	AQ
Motif Bio : Placing to raise GBP650,000	06/20/06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Motif Bio plc

Equities

MTFB

GB00BVVT4H71

All News

Filters